Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats

European Journal of Pharmacology

Volumn 724, Issue 1, 2014, Pages 132-139

  Gazal, Marta ^a   Valente, Matheus R ^a   Acosta, Bruna A ^a   Kaufmann, Fernanda N ^a   Braganhol, Elizandra ^b   Lencina, Claiton L ^b   Stefanello, Francieli M ^b   Ghisleni, Gabriele ^a   Kaster, Manuella P ^a  

^a CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Antioxidant; Curcumin; Ketamine; Keywords; Mania; Neuroprotective

Indexed keywords

CATALASE; CURCUMIN; KETAMINE; LIPID; LITHIUM CHLORIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HIPPOCAMPUS; LIPID PEROXIDATION; LOCOMOTION; MANIA; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANTIOXIDANT; CURCUMIN; KETAMINE; MANIA; NEUROPROTECTIVE;

ANIMALS; ANTIMANIC AGENTS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; CATALASE; CURCUMIN; FEMALE; HIPPOCAMPUS; KETAMINE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84892386169     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.12.028     Document Type: Article

References (52)

1. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
2. M.Y. Aksenov, and W.R. Markesbery Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease Neurosci. Lett. 302 2001 141 145
3. A.C. Andreazza, M. Kauer-Sant'anna, B.N. Frey, D.J. Bond, F. Kapczinski, L.T. Young, and L.N. Yatham Oxidative stress markers in bipolar disorder: a meta-analysis J. Affect. Disord. 111 2008 135 144
4. A.C. Andreazza, B.N. Frey, B. Erdtmann, M. Salvador, F. Rombaldi, A. Santin, C.A. Gonçalves, and F. Kapczinski DNA damage in bipolar disorder Psychiatry Res. 153 2007 27 32
5. K. Bala, B.C. Tripathy, and D. Sharma Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions Biogerontology 7 2006 81 89
6. M. Berk, F. Kapczinski, A.C. Andreazza, O.M. Dean, F. Giorlando, M. Maes, M. Yucel, C.S. Gama, S. Dodd, B. Dean, P.V. Magalhaes, P. Amminger, P. McGorry, and G.S. Malhi Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors Neurosci. Biobehav. Rev. 35 2011 804 817
7. N. Bhatia, A.S. Jaggi, N. Singh, P. Anand, and R. Dhawan Adaptogenic potential of curcumin in experimental chronic stress and chronic unpredictable stress-induced memory deficits and alterations in functional homeostasis J. Nat. Med. 65 2011 532 543
8. E. Brietzke, R.B. Mansur, A. Zugman, A.F. Carvalho, D.S. Macedo, D.S. Cha, V.C. Abilio, and R.S. McIntyre Is there a role for curcumin in the treatment of bipolar disorder? Med. Hypotheses 80 2013 606 612
9. P.S. Brocardo, J. Budni, E. Pavesi, J.L. Franco, M. Uliano-Silva, R. Trevisan, M.G. Terenzi, A.L. Dafre, and A.L. Rodrigues Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain Bipolar Disord. 12 2010 414 424
10. C.A. Bruning, M. Prigol, C. Luchese, S. Pinton, and C.W. Nogueira Diphenyl diselenide ameliorates behavioral and oxidative parameters in an animal model of mania induced by ouabain Prog. Neuropsychopharmacol. Biol. Psychiatry 38 2012 168 174
11. V. Bubenikova-Valesova, J. Svoboda, J. Horacek, and T. Sumiyoshi Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats Psychopharmacology (Berlin) 212 2010 267 276
12. E. Candelario-Jalil, S.M. Al-Dalain, R. Castillo, G. Martinez, and O.S. Fernandez Selective vulnerability to kainate-induced oxidative damage in different rat brain regions J. Appl. Toxicol. 21 2001 403 407
13. R.W. Chen, Z.H. Qin, M. Ren, H. Kanai, E. Chalecka-Franaszek, P. Leeds, and D.M. Chuang Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection J. Neurochem. 84 2003 566 575
14. F.C. da Silva, M. do Carmo de Oliveira Cito, M.I. da Silva, B.A. Moura, M.R. de Aquino Neto, M.L. Feitosa, R. de Castro Chaves, D.S. Macedo, S.M. de Vasconcelos, M.M. de Franca Fonteles, and F.C. de Sousa Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice Brain Res. Bull. 83 2010 9 15
15. H. Esterbauer, and K.H. Cheeseman Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal Methods Enzymol. 186 1990 407 421
16. B.N. Frey, S.S. Valvassori, G.Z. Reus, M.R. Martins, F.C. Petronilho, K. Bardini, F. Dal-Pizzol, F. Kapczinski, and J. Quevedo Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania J. Psychiatry Neurosci. 31 2006 326 332
17. S. Gandhi, and A.Y. Abramov Mechanism of oxidative stress in neurodegeneration Oxid. Med. Cell. Longev 2012 2012 428010 10.1155/2012/428010
18. D.M. Geddes, M.C. LaPlaca, and R.S. Cargill 2nd Susceptibility of hippocampal neurons to mechanically induced injury Exp. Neurol. 184 2003 420 427
19. F.V. Ghedim, B. Fraga Dde, P.F. Deroza, M.B. Oliveira, S.S. Valvassori, A.V. Steckert, J. Budni, F. Dal-Pizzol, J. Quevedo, and A.I. Zugno Evaluation of behavioral and neurochemical changes induced by ketamine in rats: implications as an animal model of mania J. Psychiatry Res. 46 2012 1569 1575
20. G. Golarai, A.C. Greenwood, D.M. Feeney, and J.A. Connor Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury J. Neurosci. 21 2001 8523 8537
21. T.J. Gould, R.A. Keith, and R.V. Bhat Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice Behav. Brain Res. 118 2001 95 105
22. S.C. Gupta, S. Patchva, W. Koh, and B.B. Aggarwal Discovery of curcumin, a component of golden spice, and its miraculous biological activities Clin. Exp. Pharmacol. Physiol. 39 2012 283 299
23. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine 2007 Oxford University Press New York
24. H.C. Huang, K. Xu, and Z.F. Jiang Curcumin-mediated neuroprotection against amyloid-beta-induced mitochondrial dysfunction involves the inhibition of GSK-3beta J. Alzheimers Dis. 32 2012 981 996
25. S. Jayanarayanan, S. Smijin, K.T. Peeyush, T.R. Anju, and C.S. Paulose NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: ameliorating effects of curcumin Chem. Biol. Interact. 201 2013 39 48
26. H. Jiang, Z. Wang, Y. Wang, K. Xie, Q. Zhang, Q. Luan, W. Chen, and D. Liu Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action Prog. Neuropsychopharmacol. Biol. Psychiatry 47C 2013 33 39
27. M.P. Kaster, A.O. Rosa, M.M. Rosso, E.C. Goulart, A.R. Santos, and A.L. Rodrigues Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors Neurosci. Lett. 355 2004 21 24
28. N. Katalinic, R. Lai, A. Somogyi, P.B. Mitchell, P. Glue, and C.K. Loo Ketamine as a new treatment for depression: a review of its efficacy and adverse effects Aust. N. Z. J. Psychiatry 2013
29. T. Kato, M. Kubota, and T. Kasahara Animal models of bipolar disorder Neurosci. Biobehav. Rev. 31 2007 832 842
30. S. Khurana, S. Jain, P.K. Mediratta, B.D. Banerjee, and K.K. Sharma Protective role of curcumin on colchicine-induced cognitive dysfunction and oxidative stress in rats Hum. Exp. Toxicol. 31 2012 686 697
31. S.K. Kulkarni, and A. Dhir An overview of curcumin in neurological disorders Indian J. Pharm. Sci. 72 2010 149 154
32. S.K. Kulkarni, M.K. Bhutani, and M. Bishnoi Antidepressant activity of curcumin: involvement of serotonin and dopamine system Psychopharmacology (Berlin) 201 2008 435 442
33. J.K. Lin Molecular targets of curcumin Adv. Exp. Med. Biol. 595 2007 227 243
34. M.S. Lin, K.S. Hung, W.T. Chiu, Y.Y. Sun, S.H. Tsai, J.W. Lin, and Y.H. Lee Curcumin enhances neuronal survival in N-methyl-d-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 931 938
35. B.K. Lipska, and D.R. Weinberger To model a psychiatric disorder in animals: schizophrenia as a reality test Neuropsychopharmacology 23 2000 223 239
36. A.L. Lopresti, S.D. Hood, and P.D. Drummond Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects J. Psychopharmacol. 26 2012 1512 1524
37. D.H. Lowenstein, M.J. Thomas, D.H. Smith, and T.K. McIntosh Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus J. Neurosci. 12 1992 4846 4853
38. R. Machado-Vieira Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania J. Clin. Psychopharmacol. 32 2012 735 736
39. R. Machado-Vieira, A.C. Andreazza, C.I. Viale, V. Zanatto, V. Cereser Jr., R. da Silva Vargas, F. Kapczinski, L.V. Portela, D.O. Souza, M. Salvador, and V. Gentil Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects Neurosci. Lett. 421 2007 33 36
40. R. Machado-Vieira, F. Kapczinski, and J.C. Soares Perspectives for the development of animal models of bipolar disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 28 2004 209 224
41. S.P. Mahadik, D. Evans, and H. Lal Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia Prog. Neuropsychopharmacol. Biol. Psychiatry 25 2001 463 493
42. V.P. Menon, and A.R. Sudheer Antioxidant and anti-inflammatory properties of curcumin Adv. Exp. Med. Biol. 595 2007 105 125
43. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J. Biol. Chem. 247 1972 3170 3175
44. A. Monroy, G.J. Lithgow, and S. Alavez Curcumin and neurodegenerative diseases BioFactors 39 2013 122 132
45. N. Rajasekar, S. Dwivedi, S.K. Tota, P.K. Kamat, K. Hanif, C. Nath, and R. Shukla Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice Eur. J. Pharmacol. 715 2013 381 894
46. A.K. Ricke, R.J. Snook, and A. Anand Induction of prolonged mania during ketamine therapy for reflex sympathetic dystrophy Biol. Psychiatry 70 2011 e13 14
47. S. Selek, H.A. Savas, H.S. Gergerlioglu, F. Bulbul, E. Uz, and M. Yumru The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode J. Affect. Disord. 107 2008 89 94
48. W.C. Taft, K. Yang, C.E. Dixon, and R.L. Hayes Microtubule-associated protein 2 levels decrease in hippocampus following traumatic brain injury J. Neurotrauma 9 1992 281 290
49. Y.C. Wang, E.N. Wang, C.C. Wang, C.L. Huang, and A.C. Huang Effects of lithium and carbamazepine on spatial learning and depressive behavior in a rat model of bipolar disorder induced by ouabain Pharmacol. Biochem. Behav. 105 2013 118 127
50. Y. Xu, B. Ku, L. Cui, X. Li, P.A. Barish, T.C. Foster, and W.O. Ogle Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats Brain Res. 1162 2007 9 18
51. L. Zhang, T. Xu, S. Wang, L. Yu, D. Liu, R. Zhan, and S.Y. Yu NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test Prog. Neuropsychopharmacol. Biol. Psychiatry 40 2013 12 17
52. G. Zhao, and M.P. Flavin Differential sensitivity of rat hippocampal and cortical astrocytes to oxygen-glucose deprivation injury Neurosci. Lett. 285 2000 177 180